Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $6.10 $80.02 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
May 10, 2016 $145.48 $145.48 $145.48 $145.48 908 938
May 09, 2016 $143.52 $143.52 $143.52 $143.52 949 408
May 06, 2016 $140.99 $140.99 $140.99 $140.99 933 096
May 05, 2016 $142.58 $142.58 $142.58 $142.58 1 005 004
May 04, 2016 $141.41 $141.41 $141.41 $141.41 1 280 399
May 03, 2016 $144.37 $144.37 $144.37 $144.37 2 251 185
May 02, 2016 $140.53 $140.53 $140.53 $140.53 1 360 105
Apr 29, 2016 $139.28 $139.28 $139.28 $139.28 2 046 531
Apr 28, 2016 $142.53 $142.53 $142.53 $142.53 3 267 505
Apr 27, 2016 $150.78 $150.78 $150.78 $150.78 1 861 046
Apr 26, 2016 $154.01 $154.01 $154.01 $154.01 1 450 870
Apr 25, 2016 $158.02 $158.02 $158.02 $158.02 849 024
Apr 22, 2016 $159.10 $159.10 $159.10 $159.10 1 209 033
Apr 21, 2016 $161.38 $161.38 $161.38 $161.38 1 191 756
Apr 20, 2016 $157.04 $157.04 $157.04 $157.04 821 099
Apr 19, 2016 $155.44 $155.44 $155.44 $155.44 774 929
Apr 18, 2016 $155.71 $155.71 $155.71 $155.71 988 491
Apr 15, 2016 $153.09 $153.09 $153.09 $153.09 1 566 662
Apr 14, 2016 $154.75 $154.75 $154.75 $154.75 983 352
Apr 13, 2016 $152.88 $152.88 $152.88 $152.88 1 622 309
Apr 12, 2016 $153.55 $153.55 $153.55 $153.55 1 454 317
Apr 11, 2016 $147.88 $147.88 $147.88 $147.88 1 294 025
Apr 08, 2016 $148.89 $148.89 $148.89 $148.89 1 537 400
Apr 07, 2016 $148.03 $148.03 $148.03 $148.03 2 069 263
Apr 06, 2016 $157.02 $157.02 $157.02 $157.02 2 104 814
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT